TsITOKINY: UChASTIE V PATOGENEZE I PERSPEKTIVY LEChEBNOGO PRIMENENIYa PRI BRONKhIAL'NOY ASTME
Tat'yana Vadimovna Borisova , A V Karaulov , Sergey Ivanovich Sokurenko
Journal of Clinical Practice ›› 2010, Vol. 1 ›› Issue (2) : 81 -87.
TsITOKINY: UChASTIE V PATOGENEZE I PERSPEKTIVY LEChEBNOGO PRIMENENIYa PRI BRONKhIAL'NOY ASTME
| [1] |
Kips J.C. Cytokines in asthma. ERS Journals Ltd 2001. |
| [2] |
Desai D., Brightling C. Cytokine and anti-cytokine therapy in asthma: ready for the clinic? Clinical and Experimental Immunology, 2009 158: 10-19. |
| [3] |
Кетлинский С.А., Симбирцев А.С. Цитокины, Спб, 2008 |
| [4] |
Buc M. et al. Immunopatogenesis of bronchial asthma. Arch Immunol ther exp, 2009 |
| [5] |
Yui-Hsi Wang, Yong-Jun Liu The IL-17 cytokine and their role in allergic inflammation Current opinion in Immunology, 2008 |
| [6] |
Barret N, Austen KF Innate cells and T Helper 2 Immunity in airway inflammation, Immunity, 2009 |
| [7] |
Lloyd C. M.,Hawrylowicz C. M. Regulatory T cells in asthma. Immunity. 2009 Sep 18;31(3):438-49 |
| [8] |
Holgate S Cytokine and anti-cytokine therapy for the treatment of asthma and allergic disease Cytokine, 2004. |
| [9] |
O’Byrne P, Cytokines or their Antagonists for the treatment of asthma. Chest, 2006 |
| [10] |
Haldar et al. Mepolizumab and exacerbationsa of eosinofilic refractory asthma. N Engl J Med 2009; 360: 973-84 |
| [11] |
Borish LC et al. Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial. Am J Respir Crit Care Med 1999; 160: 1816-23; |
| [12] |
Wenzel S, et al. Effect of an IL-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies. Lancet 2007; 370: 1422-31 |
| [13] |
Holgate S, Novel targets of therapy in asthma, Current opinion in pulmonary medicine, 2009 |
| [14] |
Desai D, Brightling C. Cytokine and anti-cytokine therapy in asthma: ready for the clinic? The journal of Translational Immunology, 2009. |
| [15] |
Wenzel SE, Barnes PJ et al. A randomized, double-blind, placebo-controlled study of tumor necrosis factor-α blockade in severe persistent asthma Am J Respir Crit Care Med 2009; 179:549-58. |
| [16] |
Berry M, Brightling C, Pavord I, Wardlaw A. TNF-alpha in asthma. Curr Opin Pharmacol. 2007 Jun;7(3):279-8. |
| [17] |
Brightling C , Berry M, Amrani Y. Targeting TNF-α: a novel therapeutic approach for asthma. J Allergy Clin Immunol, 2008 |
Borisova T.V., Karaulov A.V., Sokurenko S.I.
/
| 〈 |
|
〉 |